SEARCH

SEARCH BY CITATION

References

  • 1
    Ray PE, Liu XH. Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 2001; 16: 82339.
  • 2
    Camerer E, Kolsto AB, Prydz H. Cell biology of tissue factor, the principal initiator of blood coagulation. Thromb Res 1996; 81: 141.
  • 3
    Bach RR. Mechanism of tissue factor activation on cells. Blood Coagul Fibrinol Suppl 1998; 1: S3743.
  • 4
    Osterud B, Bjorklid E. The tissue factor pathway in disseminated intravascular coagulation. Semin Thromb Hemost 2001; 27: 60517.
  • 5
    Ishii H, Takada K, Higuchi T, Sugiyama J. Verotoxin-1 induces tissue factor expression in human umbilical vein endothelial cells through activation of NF-kappaB/Rel and AP-1. Thromb Haemost 2000; 84: 71221.
  • 6
    Jaffe EA, Nachman RI, Becker CG, Minick CR. Culture of human endothelial cells derived from umbilical cord veins: identification by morphologic and immunobiologic criteria. J Clin Invest 1973; 52: 274556.
  • 7
    Cresci B, Giannini S, Pala L, Mavilia C, Manuelli C, Cappugi P, Maggi E, Rotella CM, Magg E. AT1 and AT2 receptors in human glomerular endothelial cells at different passages. Microvasc Res 2003; 66: 229.
  • 8
    Shi Q, Aida K, Vandeberg JL, Wang XL. Passage-dependent changes in baboon endothelial cells—relevance to in vitro aging. DNA Cell Biol 2004; 23: 5029.
  • 9
    Balyasnikova IV, Danilov SM, Muzykantov VR, Fisher AB. Modulation of angiotensin-converting enzyme in cultured human vascular endothelial cells. In Vitro Cell Dev Biol Anim 1998; 34: 54554.
  • 10
    Grabowski EF, McDonnell SL. Human versus bovine endothelial cell culture on glass and tissue-culture plastic. J Tissue Cult Meth 1993; 15: 1908.
  • 11
    Underwood PA, Bennett FA. The effect of extracellular matrix molecules on the in vitro behavior of bovine endothelial cells. Exp Cell Res 1993; 205: 3119.
  • 12
    Morisaki N, Kanzaki T, Tamura K, Saito I, Shiina R, Saito Y. Specific inhibition of vascular cell adhesion molecule-1 expression by type IV collagen in endothelial cells. Biochem Biophys Res Commun 1995; 214: 11637.
  • 13
    Berge N, Loganadane LD, Vassy J, Monnet E, Legrand C, Fauvel-Lafeve F. Adhesion-induced intracellular signalling in endothelial cells depends on the nature of the matrix. Cell Adhes Commun 1999; 7: 2941.
  • 14
    Yagi H, Narita N, Matsumoto M, Sakurai Y, Ikari H, Yoshioka A, Kita E, Ikeda Y, Titani K, Fujimura Y. Enhanced low shear stress induced platelet aggregation by Shiga-like toxin 1 purified from Escherichia coli O157. Am J Hematol 2001; 66: 10515.
  • 15
    Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual, 2nd edn. New York: Cold Spring. Harbor Laboratory Press, 1989.
  • 16
    Sase T, Hideo W, Nishioka J, Abe Y, Gabazza EC, Shiku H, Suzuki K, Nakamura S, Nobori T. Measurement of tissue factor messenger RNA levels in leukocytes from patients in hypercoagulable state caused by several underlying diseases. Thromb Haemost 2003; 89: 6605.
  • 17
    Ramakers C, Ruijter J, Lekanne Deprez RH, Moorman AFM. Assumption-free analysis of quantitative real-time polymerase chain reaction (PCR) data. Neuroscience Lett 2003; 339: 626.
  • 18
    Pfaffl MW. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 2001; 29: 20027.
  • 19
    Matsumoto Y, Kawai Y, Watanabe K, Sakai K, Murata M, Handa M, Nakamura S, Ikeda Y. Fluid shear stress attenuates tumor necrosis factor-alpha-induced tissue factor expression in cultured human endothelial cells. Blood 1998; 91: 416472.
  • 20
    Pijpers AH, Van Setten PA, Van Den Heuvel LP, Assmann KJ, Dijkman HB, Pennings AH, Monnens LA, Van Hinsbergh VW. Verocytotoxin-induced apoptosis of human microvascular endothelial cells. J Am Soc Nephrol 2001; 12: 76778.
  • 21
    Van De Kar NC, Monnens LA, Karmali MA, Van Hinsbergh VW. Tumor necrosis factor and interleukin-1 induce expression of the verocytotoxin receptor globotriaosylceramide on human endothelial cells: implications for the pathogenesis of the hemolytic uremic syndrome. Blood 1992; 80: 275564.
  • 22
    Van Setten PA, Van Hinsbergh VW, Van Der Velden TJ, Van De Kar NC, Vermeer M, Mahan JD, Assmann KJ, Van Den Heuvel LP, Monnens LA. Effects of TNF alpha on verocytotoxin cytotoxicity in purified human glomerular microvascular endothelial cells. Kidney Int 1997; 51: 124556.
  • 23
    Ramegowda B, Samuel JE, Tesh VL. Interaction of Shiga toxins with human brain microvascular endothelial cells: cytokines as sensitizing agents. J Infect Dis 1999; 180: 120513.
  • 24
    Ergonul Z, Hughes AK, Kohan DE. Induction of apoptosis of human brain microvascular endothelial cells by Shiga toxin 1. J Infect Dis 2003; 187: 1548.
  • 25
    Giesen PL, Rauch U, Bohrmann B, Kling D, Roque M, Fallon JT, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Blood-borne tissue factor. another view of thrombosis. Proc Natl Acad Sci USA 1999; 96: 231115.
  • 26
    Rauch U, Bonderman D, Bohmann B, Badimon JJ, Himber J, Riederer MA, Nemerson Y. Transfer of tissue factor from leucocytes to platelets is mediated by CD15 and tissue factor. Blood 2000; 96: 1705.
  • 27
    Balasubramanian V, Grabowski E, Bini A, Nemerson Y. Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: real-time fluorescence images of thrombus formation and propagation under defined flow conditions. Blood 2002; 100: 278792.
  • 28
    Bogdanov VY, Balasubramanian V, Hathcock J, Vele O, Lieb M, Nemerson Y. Alternatively spliced human tissue factor: a circulating, soluble, thrombogenic protein. Nat Med 2003; 9: 45862.
  • 29
    Greeno EW, Bach RR, Moldow CF. Apoptosis is associated with increased cell surface tissue factor procoagulant activity. Lab Invest 1996; 75: 2819.
  • 30
    Bach RR, Moldow CF. Mechanism of tissue factor activation on HL-60 cells. Blood 1997; 89: 32706.
  • 31
    Sevinsky JR, Rao LV, Ruf W. Ligand-induced protease receptor translocation into caveolae: a mechanism for regulating cell surface proteolysis of the tissue factor-dependent coagulation pathway. J Cell Biol 1996; 133: 293304.
  • 32
    Wolberg AS, Monroe DM, Roberts HR, Hoffman MR. Tissue factor deencryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanisms. Blood Coagul Fibrinol 1999; 10: 20110.
  • 33
    Bombeli T, Karsan A, Tait JF, Harlan JM. Apoptotic vascular endothelial cells become procoagulant. Blood 1997; 89: 242942.
  • 34
    Ohmi K, Kiyokawa N, Takeda T, Fujimoto J. Human microvascular endothelial cells are strongly sensitive to Shiga toxins. Biochem Biophys Res Commun 1998; 251: 13741.
  • 35
    Louise CB, Obrig TG. Specific interaction of Escherichia coli O157: H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 1995; 172: 1397401.
  • 36
    Obrig TG, Louise CB, Lingwood CA, Boyd B, Barley-Maloney L, Daniel TO. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 1993; 268: 154848.
  • 37
    Harel Y, Silva M, Giroir B, Weinberg A, Cleary TB, Beutler B. A reporter transgene indicates renal-specific induction of tumor necrosis factor (TNF) by Shiga-like toxin. Possible involvement of TNF in hemolytic uremic syndrome. J Clin Invest 1993; 92: 211016.
  • 38
    Kaufmann JE, Oksche A, Wollheim CB, Gunther G, Rosenthal W, Vischer UM. Vasopressin-induced von Willebrand factor secretion from endothelial cells involves V2 receptors and cAMP. J Clin Invest 2000; 106: 10716.
  • 39
    Miyashita T, Takeishi Y, Takahashi H, Miyamoto T, Fujii S, Yoshimura T, Tomoike H, Kato S, Kubota I. Comparison of nitric oxide production in response to carbachol between macrovascular and microvascular cardiac endothelial cells. Circ J 2002; 66: 51115.
  • 40
    Grafe M, Auch-Schwelk W, Hertel H, Terbeek D, Steinheider G, Loebe M, Fleck E. Human cardiac microvascular and macrovascular endothelial cells respond differently to oxidatively modified LDL. Atherosclerosis 1998; 137: 8795.
  • 41
    Chandler WL, Jelacic S, Boster DR, Ciol MA, Williams GD, Watkins SL, Igarashi T, Tarr PI. Prothrombotic coagulation abnormalities preceding the hemolytic–uremic syndrome. N Engl J Med 2002; 346: 2332.
  • 42
    Van Geet C, Proesmans W, Arnout J, Vermylen J, Declerck PJ. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome. Kidney Int 1998; 54: 132430.
  • 43
    Nevard CH, Blann AD, Jurd KM, Haycock GB, Hunt BJ. Markers of endothelial cell activation and injury in childhood hemolytic uremic syndrome. Pediatr Nephrol 1999; 13: 48792.